A popular class of diabetes medications called GLP-1R agonists (Trulicity and Rybelsus) may also protect against glaucoma in diabetic patients, according to a new study led by researchers in the Scheie Eye Institute at the ...
Sep 20, 2021
0
16
Groups who suffer the highest burden of type 2 diabetes have the lowest level of adherence to effective medication to control it, a University of Otago study has found.
Aug 5, 2021
0
25
A 15-center study of 175 patients with poorly-controlled type 2 diabetes in JAMA found that continuous glucose monitoring, compared to blood glucose meter monitoring, or finger pricking, significantly decreased their hemoglobin ...
Jul 26, 2021
0
280
This year marks the 100th anniversary of the discovery of insulin, a scientific breakthrough that transformed Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, from a terminal disease into a ...
Jun 30, 2021
0
36
A group of Oakland University researchers used data from medical studies around the world to examine the impact of resistance training on type 2 diabetes risk.
Jun 17, 2021
0
6
Millions of people with diabetes are at risk of developing foot ulcers, which often lead to amputations and other health complications. Now, Scientists from the Centre for Biomechanics and Rehabilitation Technologies (CRBT) ...
Jun 10, 2021
0
10
Type 2 diabetes patients who are not overweight and who have had the disorder for less than a decade can benefit from stromal stem cells transplanted from their own bone marrow, according to a study published today in STEM ...
Jun 3, 2021
0
3
In patients with insulin-treated type 2 diabetes, the use of continuous glucose monitors is associated with better blood sugar control and fewer visits to the emergency room for hypoglycemia, a Kaiser Permanente study published ...
Jun 2, 2021
0
5
A clinical study led by Linköping University, Sweden, and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type 1 diabetes can preserve the body's own production of insulin. ...
May 24, 2021
0
34
(HealthDay)—Black and Hispanic or Latinx participants are underrepresented in clinical trials for ophthalmology drugs, according to a study published online April 22 in JAMA Ophthalmology.
Apr 27, 2021
0
2
